| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1007/S11886-008-0070-9 |
| P698 | PubMed publication ID | 18950552 |
| P50 | author | Ralf Dechend | Q63812628 |
| Friedrich Luft | Q20753057 | ||
| P2860 | cites work | Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial | Q46351253 |
| Circulating angiogenic factors and the risk of preeclampsia | Q47217679 | ||
| Is parvovirus B19 the cause for autoimmunity against the angiotensin II type receptor? | Q52928690 | ||
| Relation between circulating angiotensin II type 1 receptor agonistic autoantibodies and soluble fms-like tyrosine kinase 1 in the pathogenesis of preeclampsia. | Q52933863 | ||
| Agonistic autoantibodies to the AT1 receptor in a transgenic rat model of preeclampsia. | Q52940276 | ||
| Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. | Q53600812 | ||
| Temporal relationships between hormonal and hemodynamic changes in early human pregnancy. | Q54112770 | ||
| Hemodynamic measurements in preeclampsia: preliminary observations. | Q54467572 | ||
| Urinary Placental Growth Factor and Risk of Preeclampsia | Q56619498 | ||
| Agonistic Angiotensin II Type 1 Receptor Autoantibodies in Postpartum Women With a History of Preeclampsia | Q56981931 | ||
| Dysregulation of the Circulating and Tissue-Based Renin-Angiotensin System in Preeclampsia | Q56981959 | ||
| Rats transgenic for human renin and human angiotensinogen as a model for gestational hypertension | Q73128397 | ||
| Autoantibodies against the angiotensin receptor (AT1) in patients with hypertension | Q74126541 | ||
| Possible molecular mechanisms involved in the toxicity of angiogenesis inhibition | Q80376810 | ||
| Angiotensin II type 1 receptor agonistic antibodies reflect fundamental alterations in the uteroplacental vasculature | Q81423834 | ||
| Pre-eclampsia | Q81446389 | ||
| VEGF inhibition and renal thrombotic microangiopathy | Q24632792 | ||
| Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data | Q28211057 | ||
| Soluble endoglin contributes to the pathogenesis of preeclampsia | Q28244053 | ||
| Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia | Q29615916 | ||
| Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor | Q33848380 | ||
| Pregnancy, vascular tone, and maternal hemodynamics: a crucial adaptation | Q34024407 | ||
| Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomised placebo-controlled trial. | Q34514153 | ||
| Autoantibody from women with preeclampsia induces soluble Fms-like tyrosine kinase-1 production via angiotensin type 1 receptor and calcineurin/nuclear factor of activated T-cells signaling | Q35681804 | ||
| Angiotensin II induces soluble fms-Like tyrosine kinase-1 release via calcineurin signaling pathway in pregnancy | Q35699115 | ||
| Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice | Q35701236 | ||
| Relaxin is essential for renal vasodilation during pregnancy in conscious rats | Q36167196 | ||
| The vascular actions of relaxin | Q37045606 | ||
| Relaxin-family peptide and receptor systems in brain: insights from recent anatomical and functional studies | Q37045617 | ||
| Maternal autoantibodies from preeclamptic patients activate angiotensin receptors on human trophoblast cells | Q44320558 | ||
| AT1 receptor agonistic antibodies from preeclamptic patients stimulate NADPH oxidase | Q44385661 | ||
| Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia | Q44434565 | ||
| Essential Role for Vascular Gelatinase Activity in Relaxin-Induced Renal Vasodilation, Hyperfiltration, and Reduced Myogenic Reactivity of Small Arteries | Q44639210 | ||
| Antibodies from preeclamptic patients stimulate increased intracellular Ca2+ mobilization through angiotensin receptor activation | Q45069619 | ||
| Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection | Q45259438 | ||
| Maternal autoantibodies from preeclamptic patients activate angiotensin receptors on human mesangial cells and induce interleukin-6 and plasminogen activator inhibitor-1 secretion | Q46344658 | ||
| P433 | issue | 6 | |
| P921 | main subject | pre-eclampsia | Q61335 |
| maternal health | Q6786626 | ||
| P304 | page(s) | 440-447 | |
| P577 | publication date | 2008-11-01 | |
| P1433 | published in | Current cardiology reports | Q26842345 |
| P1476 | title | Are we getting closer to a Nobel prize for unraveling preeclampsia? | |
| P478 | volume | 10 |
| Q28069689 | A Dormant Microbial Component in the Development of Preeclampsia |
| Q44441131 | Early antenatal serum lipid levels and the risk of pre-eclampsia in Trinidad and Tobago |
| Q26744192 | G-Protein-coupled receptors as potential drug candidates in preeclampsia: targeting the relaxin/insulin-like family peptide receptor 1 for treatment and prevention |
| Q35029700 | Hypertension in response to placental ischemia during pregnancy: role of B lymphocytes |
| Q37786350 | Immunologic characteristics of preeclampsia, a comprehensive review |
| Q38080804 | Relaxin: new pathophysiological aspects and pharmacological perspectives for an old protein |
Search more.